Abstract: Provided herein are IL-2 muteins, IL-2 mutein Fc-fusion molecules, anti-IL-2 antibodies, and complexes comprising an anti IL-2 antibody bound to an IL-2 cytokine that preferentially expand and activate T regulatory cells and are amenable to large scale production. Also provided herein are variant human IgG1 Fc molecules lacking or with highly reduced effector function and high stability despite lacking glycosylation at N297. Also provided herein are linker peptides that are glycosylated when expressed in mammalian cells. Also provided herein are methods of making and using the compositions of the present invention.

Abstract: Provided herein are IL-2 muteins, IL-2 mutein Fc-fusion molecules, anti-IL-2 antibodies, and complexes comprising an anti IL-2 antibody bound to an IL-2 cytokine that preferentially expand and activate T regulatory cells and are amenable to large scale production. Also provided herein are variant human IgG1 Fc molecules lacking or with highly reduced effector function and high stability despite lacking glycosylation at N297. Also provided herein are linker peptides that are glycosylated when expressed in mammalian cells. Also provided herein are methods of making and using the compositions of the present invention.

Abstract: Provided herein are IL-2 muteins, IL-2 mutein Fc-fusion molecules, anti-IL-2 antibodies, and complexes comprising an anti IL-2 antibody bound to an IL-2 cytokine that preferentially expand and activate T regulatory cells and are amenable to large scale production. Also provided herein are variant human IgG1 Fc molecules lacking or with highly reduced effector function and high stability despite lacking glycosylation at N297. Also provided herein are linker peptides that are glycosylated when expressed in mammalian cells. Also provided herein are methods of making and using the compositions of the present invention.

Abstract: A container comprises a body defined by a top and bottom, wherein the top and bottom are separated by one or more sidewalls, wherein the top has an opening extending into a hollow interior. a plurality of material strips are sequentially disposed within the body, wherein the plurality of material strips are removed from within the body in sequential order A secondary container is in communication with the body, wherein the secondary container receives each of the plurality of strips after they have been removed from the body.

Abstract: Provided herein are IL-2 muteins, IL-2 mutein Fc-fusion molecules, anti-IL-2 antibodies, and complexes comprising an anti IL-2 antibody bound to an IL-2 cytokine that preferentially expand and activate T regulatory cells and are amenable to large scale production. Also provided herein are variant human IgG1 Fc molecules lacking or with highly reduced effector function and high stability despite lacking glycosylation at N297. Also provided herein are linker peptides that are glycosylated when expressed in mammalian cells. Also provided herein are methods of making and using the compositions of the present invention.

Abstract: Provided herein are IL-2 muteins, IL-2 mutein Fc-fusion molecules, anti-IL-2 antibodies, and complexes comprising an anti IL-2 antibody bound to an IL-2 cytokine that preferentially expand and activate T regulatory cells and are amenable to large scale production. Also provided herein are variant human IgG1 Fc molecules lacking or with highly reduced effector function and high stability despite lacking glycosylation at N297. Also provided herein are linker peptides that are glycosylated when expressed in mammalian cells. Also provided herein are methods of making and using the compositions of the present invention.

Abstract: A container comprises a body defined by a top and bottom, wherein the top and bottom are separated by one or more sidewalls, wherein the top has an opening extending into a hollow interior. a plurality of material strips are sequentially disposed within the body, wherein the plurality of material strips are removed from within the body in sequential order A secondary container is in communication with the body, wherein the secondary container receives each of the plurality of strips after they have been removed from the body.

Abstract: Various embodiments include a system having interfaces, storage devices, memory, and processing circuitry. The system may be coupled with one or more storage devices and may receive episode information for a patient from a storage device via one or more wired or wireless links, the episode information includes a plurality of episodes associated with the patient, each of the plurality of episodes is a specific instance of a medical condition. The system may generate a candidate episode pairs list comprising a plurality of candidate episode pairs. Embodiments may also include the system generating a transition list comprising episode pairs from the plurality of candidate episode pairs in the candidate episode pairs list and determining attribute relationships between the plurality of episodes for the patient based on episode pairs in the transition list, the attribute relationships used to attribute items between the plurality of episodes.

Abstract: Various embodiments include a system having interfaces, storage devices, memory, and processing circuitry. The system may be coupled with one or more storage devices and may receive episode information for a patient from a storage device via one or more wired or wireless links, the episode information includes a plurality of episodes associated with the patient, each of the plurality of episodes is a specific instance of a medical condition. The system may generate a candidate episode pairs list comprising a plurality of candidate episode pairs. Embodiments may also include the system generating a transition list comprising episode pairs from the plurality of candidate episode pairs in the candidate episode pairs list and determining attribute relationships between the plurality of episodes for the patient based on episode pairs in the transition list, the attribute relationships used to attribute items between the plurality of episodes.

Abstract: A soybean cultivar designated HFPR-5 is disclosed. The invention relates to the seeds of soybean cultivar HFPR-5, to the plants of soybean HFPR-5, to plant parts of soybean cultivar HFPR-5 and to methods for producing a soybean plant produced by crossing soybean cultivar HFPR-5 with itself or with another soybean variety. The invention also relates to methods for producing a soybean plant containing in its genetic material one or more transgenes and to the transgenic soybean plants and plant parts produced by those methods. This invention also relates to soybean cultivars or breeding cultivars and plant parts derived from soybean variety HFPR-5, to methods for producing other soybean cultivars, lines or plant parts derived from soybean cultivar HFPR-5 and to the soybean plants, varieties, and their parts derived from use of those methods. The invention further relates to hybrid soybean seeds, plants and plant parts produced by crossing the cultivar HFPR-5 with another soybean cultivar.

Abstract: A soybean cultivar designated HFPR-5 is disclosed. The invention relates to the seeds of soybean cultivar HFPR-5, to the plants of soybean HFPR-5, to plant parts of soybean cultivar HFPR-5 and to methods for producing a soybean plant produced by crossing soybean cultivar HFPR-5 with itself or with another soybean variety. The invention also relates to methods for producing a soybean plant containing in its genetic material one or more transgenes and to the transgenic soybean plants and plant parts produced by those methods. This invention also relates to soybean cultivars or breeding cultivars and plant parts derived from soybean variety HFPR-5, to methods for producing other soybean cultivars, lines or plant parts derived from soybean cultivar HFPR-5 and to the soybean plants, varieties, and their parts derived from use of those methods. The invention further relates to hybrid soybean seeds, plants and plant parts produced by crossing the cultivar HFPR-5 with another soybean cultivar.